Don't miss real-time top news, insights, and interviews with the experts direct from the conference floor in Chicago. Sign up now to be reminded to tune in to OncLive News Network: On Location in Chicago.

Association of Community Cancer Centers Relaunches Immuno-Oncology Initiative to Meet Evolving Needs of Oncology Community

Thursday, November 29, 2018
The Association of Community Cancer Centers (ACCC) announced today the relaunch of the ACCC Immuno-Oncology Institute including an online resource portal for oncology professionals to find practical, proactive strategies for the effective delivery of new and emerging therapies. ACCC worked closely with a team of multispecialty thought leaders via the IO Institute Working Groups to develop forward-thinking resources at the intersection of clinical science, care delivery, business, operations, and policy to support all facets of immunotherapy integration.
 
The ACCC Immuno-Oncology Institute is the only initiative dedicated to educating multidisciplinary teams to go beyond a clinical understanding of IO and tackle real-world implementation issues. With the care of patients on immunotherapies now extending beyond the cancer team, the ACCC Immuno-Oncology Institute is at the forefront of developing critical education to empower healthcare professionals across care delivery settings.
 
“As IO has advanced at a rapid pace, there was a need to evolve our Institute,” said Lee S. Schwartzberg, MD, FACP Chair, ACCC IO Institute Executive Committee. “From quick takeaways to a thought-provoking "Immuno-Oncology Insights" series; eLearning courses, webinars, and videos; and our comprehensive, end-of-year publication, the ACCC Immuno-Oncology Institute is developing an extensive collection of operational, clinical, and administrative tools that are designed to meet professional interests and demanding schedules.”
 
Resources available on the ACCC Immuno-Oncology Institute web portal address the following topics:
 Care Coordination & Communication
  • Immune-Related Adverse Events
  • Novel Therapies
  • Policy & Reimbursement
  • Managing Survivorship
  • Tele-medicine & Virtual Navigation
 The ACCC Immuno-Oncology Institute is supported by Bristol-Myers Squibb; EMD Serono; Kite, a Gilead Company; and Merck & Co, Inc.

 
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2018
Intellisphere, LLC. All Rights Reserved.